Invention Grant
- Patent Title: 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
-
Application No.: US16381163Application Date: 2019-04-11
-
Publication No.: US10550129B2Publication Date: 2020-02-04
- Inventor: Tatsuki Koike , Masato Yoshikawa , Haruhi Ando , William John Farnaby
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2011-222741 20111007
- Main IPC: C07D498/08
- IPC: C07D498/08 ; C07D401/10 ; C07D401/14 ; C07D405/10 ; C07D405/14 ; C07D413/10 ; C07D413/14 ; C07D417/14
Abstract:
The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20190233436A1 1-ARYLCARBONYL-4-OXY-PIPERIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Public/Granted day:2019-08-01
Information query
